FOLD – amicus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
11/16
03:06 am
fold
Low
Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
11/12
10:45 am
fold
Low
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at JPMorgan Chase & Co. from $16.00 to $17.00. They now have an "overweight" rating on the stock.
11/8
07:08 am
fold
Low
Amicus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
11/7
02:34 pm
fold
Low
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target raised by analysts at Guggenheim from $13.00 to $15.00. They now have a "buy" rating on the stock.
11/7
12:35 pm
fold
Low
Amicus' Q3 Earnings & Revenues Beat Estimates, '24 View Updated [Yahoo! Finance]
11/6/2024
07:00 am
fold
-11.4%
BEAT
8/8/2024
07:00 am
fold
14.9%
BEAT
5/9/2024
07:00 am
fold
-6.6%
MISS
2/28/2024
07:00 am
fold
-10.1%
BEAT
11/12
10:12 am
Maintains
Overweight
Overweight
JP Morgan
Low
-2.5%
11/7
02:22 pm
Maintains
Buy
Buy
Guggenheim
Low
0.9%
11/7
02:22 pm
Maintains
Buy
Buy
Guggenheim
Low
0.9%
11/7
10:41 am
Maintains
Overweight
Overweight
Cantor Fitzgerald
Low
1.2%
11/7
08:36 am
Reiterates
Hold
Needham & Company LLC
Low
-0.2%
11/14
09:01 pm
fold
Medium
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Redmile Group, LLC
11/14
11:37 am
fold
Low
Form SC 13G AMICUS THERAPEUTICS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
11/14
09:32 am
fold
Low
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: Avoro Capital Advisors LLC
11/8
10:53 am
fold
Low
Form SC 13G/A AMICUS THERAPEUTICS, Filed by: WELLINGTON MANAGEMENT GROUP LLP
11/7
05:52 pm
fold
Low
Form 4 AMICUS THERAPEUTICS, For: Nov 06 Filed by: Campbell Bradley L
Show more
Top News Gainers
4/2 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 8.5%
2/4 Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $20.00 price target on the stock, up previously from $19.00. 7.0%
3/9 Form 4 AMICUS THERAPEUTICS, For: Mar 05 Filed by: Campbell Bradley L 6.9%
2/4 Form 4 AMICUS THERAPEUTICS, For: Jan 31 Filed by: Crowley John F 6.5%
6/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 5.8%
1/14 Form 4 AMICUS THERAPEUTICS, For: Jan 10 Filed by: Barth Jay 5.4%
10/3 Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) A Volatile Stock? [Yahoo! Finance News] 4.8%
3/24 Form 4 AMICUS THERAPEUTICS, For: Mar 20 Filed by: Crowley John F 4.4%
7/17 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was given a new $18.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock. 4.4%
4/24 Amicus Therapeutics to Announce First Quarter 2020 Financial Results on May 7, 2020 4.3%
Top News Decliners
10/3 Amicus snaps back on positive data from Pompe Disease study of AT-GAA [Seeking Alpha] -10.0%
8/2 Amicus Therapeutics Receives Marketing Authorization for Galafold® (migalastat) for Fabry Disease in Argentina -9.0%
3/2 Amicus Therapeutics Announces Full-Year 2019 Financial Results and 2020 Corporate Updates -8.4%
8/8 Amicus Therapeutics, Inc. (FOLD) CEO John Crowley on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -7.5%
5/29 Amicus Therapeutics Announces Public Offering of Common Stock -7.2%
12/4 Form 4 AMICUS THERAPEUTICS, For: Dec 02 Filed by: Crowley John F -6.8%
8/8 Q2/2019 6/30/2019 EPS -0.360 ZacksConsensus -0.340 ActVsEst (0.020) - Miss -6.7%
7/4 Why Amicus Therapeutics' Stock Perked Up in June [The Motley Fool] -6.2%
1/18 Amicus Therapeutics, Inc. (NASDAQ: FOLD) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -6.0%
1/13 Form 8-K AMICUS THERAPEUTICS, For: Jan 13 -5.7%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3